Aeolus Pharmaceuticals Inc (AOLS) financial statements (2020 and earlier)

Company profile

Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150
MISSION VIEJO, CA 92691
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30210
Cash and cash equivalents30210
Receivables12201
Prepaid expense and other current assets0
Other undisclosed current assets0001 
Total current assets:42421
Noncurrent Assets
Long-term investments and receivables00000
Long-term investments00000
Deferred costs 001 
Other undisclosed noncurrent assets (0)(0)(1)(0)
Total noncurrent assets:00000
TOTAL ASSETS:42421
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12212
Other undisclosed accounts payable and accrued liabilities12212
Debt 1   
Deferred revenue and credits 001 
Other undisclosed current liabilities 0   
Total current liabilities:13212
Noncurrent Liabilities
Other undisclosed noncurrent liabilities    19
Total noncurrent liabilities:    19
Total liabilities:132122
Stockholders' equity
Stockholders' equity attributable to parent, including:3(1)21(20)
Preferred stock 0000
Common stock21111
Additional paid in capital192184184183160
Accumulated deficit(190)(187)(184)(184)(181)
Warrants and rights outstanding 0  19
Other undisclosed stockholders' equity attributable to parent (0)  (19)
Total stockholders' equity:3(1)21(20)
TOTAL LIABILITIES AND EQUITY:42421

Income statement (P&L) ($ in millions)

9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
Revenues
(Revenue, Net)
231047
Cost of revenue   (1) 
Gross profit:231037
Operating expenses(5)(6)(10)(6)(10)
Other undisclosed operating income 00  
Operating loss:(3)(3)(0)(3)(2)
Interest and debt expense(0)(0)   
Loss from continuing operations before income taxes:(4)(3)(0)(3)(2)
Income tax expense (0)(0)(0)(0)
Net loss:(4)(3)(0)(3)(2)
Other undisclosed net income (loss) attributable to parent 00(1)4
Net income (loss) attributable to parent:(4)(3)(0)(3)2
Other undisclosed net loss available to common stockholders, basic(2)    
Net income (loss) available to common stockholders, diluted:(6)(3)(0)(3)2

Comprehensive Income ($ in millions)

9/30/2016
9/30/2015
9/30/2014
9/30/2013
9/30/2012
Net loss:(4)(3)(0)(3)(2)
Comprehensive loss, net of tax, attributable to parent:(4)(3)(0)(3)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: